Cargando…

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis

BACKGROUND: Regorafenib (REG) is an oral multikinase inhibitor used in colorectal cancer, gastrointestinal stromal tumour and hepatocellular carcinoma. Several adverse events (AEs) are commonly reported during REG administration, and strategies for managing AEs in everyday clinical practice include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rizzo, Alessandro, Nannini, Margherita, Novelli, Marco, Dalia Ricci, Angela, Scioscio, Valerio Di, Pantaleo, Maria Abbondanza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343359/ https://www.ncbi.nlm.nih.gov/pubmed/32684988 http://dx.doi.org/10.1177/1758835920936932

Ejemplares similares

Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GIST
por: Nannini, Margherita, et al.
Publicado: (2020)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
por: Su, Guan-Li, et al.
Publicado: (2020)

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review
por: Wu, Yinying, et al.
Publicado: (2020)

Adverse Events Related to Tirzepatide
por: Mishra, Rahul, et al.
Publicado: (2023)

High-dose versus low-dose angiotensin converting enzyme inhibitors in heart failure: systematic review and meta-analysis
por: Migliavaca, Celina Borges, et al.
Publicado: (2020)

Comparison of Regorafenib, Fruquintinib, and TAS-102 in Previously Treated Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis of Five Clinical Trials
por: Chen, Jianxin, et al.
Publicado: (2019)

A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib
por: Nix, Ryan, et al.
Publicado: (2019)

Effects of high-dose versus low-dose proton pump inhibitors for treatment of gastrointestinal ulcer bleeding: a meta-analysis of randomized controlled trials
por: Zhu, Wei, et al.
Publicado: (2022)

Same-day single-dose vs large-volume split-dose regimens of polyethylene glycol for bowel preparation: A systematic review and meta-analysis
por: Pan, Hui, et al.
Publicado: (2022)

Meta-analysis of incidence and risk of severe adverse events and fatal adverse events with crizotinib monotherapy in patients with ALK-positive NSCLC
por: Zhu, Qian, et al.
Publicado: (2017)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis
por: Xu, Jia-Ying, et al.
Publicado: (2016)

Pain reduction and adverse effects of intravenous metoclopramide for acute migraine attack: A systematic review and meta-analysis of randomized-controlled trials
por: Ungrungseesopon, Nat, et al.
Publicado: (2022)

Tooth loss and cancer risk: a dose–response meta analysis of prospective cohort studies
por: Shi, Jun, et al.
Publicado: (2017)

Coffee consumption and risk of myocardial infarction: a dose-response meta-analysis of observational studies
por: Mo, Long, et al.
Publicado: (2018)

Effectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials
por: Zhang, Jing-Zhan, et al.
Publicado: (2020)

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β(2)-agonist fixed-dose combinations in COPD
por: Siddiqui, Mohd Kashif, et al.
Publicado: (2019)

What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis
por: Chen, Yong, et al.
Publicado: (2017)

Benzodiazepine drug use and cancer risk: a dose–response meta analysis of prospective cohort studies
por: Zhang, Tao, et al.
Publicado: (2017)

Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events
por: Mashiana, Harmeet Singh, et al.
Publicado: (2018)

Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis
por: Wang, Hao, et al.
Publicado: (2021)

Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis
por: Xu, Wentao, et al.
Publicado: (2023)

Potassium measurements and risk of type 2 diabetes: a dose-response meta-analysis of prospective cohort studies
por: Peng, Yang, et al.
Publicado: (2017)

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
por: Berretta, Massimiliano, et al.
Publicado: (2018)

Association between tea consumption and risk of cognitive disorders: A dose-response meta-analysis of observational studies
por: Liu, Xueying, et al.
Publicado: (2017)

Physical activity and the risk of heart failure: a systematic review and dose–response meta-analysis of prospective studies
por: Aune, Dagfinn, et al.
Publicado: (2020)

Accuracy of baseline low-dose computed tomography lung cancer screening: a systematic review and meta-analysis
por: Guo, Lanwei, et al.
Publicado: (2023)

Physical activity and the risk of gestational diabetes mellitus: a systematic review and dose–response meta-analysis of epidemiological studies
por: Aune, Dagfinn, et al.
Publicado: (2016)

Associations between dietary folate intake and risks of esophageal, gastric and pancreatic cancers: an overall and dose-response meta-analysis
por: Liu, Wen, et al.
Publicado: (2017)

Body mass index and incidence of nonaggressive and aggressive prostate cancer: a dose-response meta-analysis of cohort studies
por: Xie, Bo, et al.
Publicado: (2017)

Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
por: Du, Jing, et al.
Publicado: (2017)

Tea consumption and the risk of biliary tract cancer: a systematic review and dose–response meta-analysis of observational studies
por: Xiong, Jianping, et al.
Publicado: (2017)

The role of perioperative intravenous low-dose dexamethasone in rapid recovery after total knee arthroplasty: a meta-analysis
por: Zhuo, Youguang, et al.
Publicado: (2021)

Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis
por: Zhou, Na, et al.
Publicado: (2023)

Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis
por: Nso, Nso, et al.
Publicado: (2020)

Glycemic Index, Glycemic Load, Carbohydrates, and Type 2 Diabetes: Systematic review and dose–response meta-analysis of prospective studies
por: Greenwood, Darren C., et al.
Publicado: (2013)

Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-analysis
por: Ding, Ming, et al.
Publicado: (2014)

Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies
por: Wang, Yaqin, et al.
Publicado: (2017)

Efficacy Evaluation of High-Dose Atorvastatin Pretreatment in Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Ma, YanFeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dumeo0gfpc4dbm2r9s33g76v84